The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants

The clinical usefulness of post-diagnosis islet autoantibody levels is unclear and factors that drive autoantibody persistence are poorly defined in type 1 diabetes (T1D). Our aim was to characterise the longitudinal loss of islet autoantibody responses after diagnosis in a large, prospectively samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, C L, Fareed, R, Mortimer, G L M, Aitken, R J, Wilson, I V, George, G, Gillespie, K M, Williams, A J K, Long, A E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Autoimmunity/Autoimmune disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750828/
https://www.ncbi.nlm.nih.gov/pubmed/36181724
http://dx.doi.org/10.1093/cei/uxac087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750828/
https://www.ncbi.nlm.nih.gov/pubmed/36181724
http://dx.doi.org/10.1093/cei/uxac087

Ejemplares similares